Theriva Biologics
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|
Revenue | $300 | $0 | $0 |
Gross Profit | 276 | -27 | |
EBITDA | -2,020 | -1,969 | -4,333 |
EBIT | -2,044 | -1,996 | -4,361 |
Net Income | -2,044 | -1,996 | -4,361 |
Net Change In Cash | 300 | 0 | 0 |
Free Cash Flow | -2,456 | -2,882 | -4,338 |
Cash | 14,431 | 13,056 | 7,528 |
Basic Shares | 41,072 | 12,140 | 9,676 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -108 | -137 | -135 | -268 |
EBITDA | -23,631 | -19,290 | -21,956 | -19,205 |
EBIT | -23,739 | -19,427 | -22,091 | -19,290 |
Net Income | -25,249 | -25,653 | -18,349 | -19,685 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -16,704 | -16,938 | -19,198 | -19,198 |
Cash | 13,056 | 11,609 | 23,177 | 41,786 |
Basic Shares | 12,140 | 1,348 | 644 | 613 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.07 |
2026-03-31 | -$0.05 |
2025-12-31 | -$0.09 |
2025-09-30 | -$0.45 |